Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Harvest Integrated Research Organization (HiRO) is a globally oriented, innovative clinical research organization (CRO).
Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer.
TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.
Gennao Bio is a genetic medicines company that develops targeted nucleic acid therapeutics to cure muscle diseases.
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
PierianDx is catalyzing global adoption of genomic sequencing in healthcare
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.
Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.
A private biopharmaceutical company .
GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Turnstone Biologics is a privately-held clinical stage biotech company.
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
NeRRe Therapeutics is a biotechnology company that develops clinical and pre-clinical neurokinin receptor antagonists.
Stairway Medical is a developer of implantable brain-computer interface technology.
QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.
Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.
Started in 2013, Redcliffe Hygiene Private Limited is India's fastest growing hygiene company.
AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.
Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.
BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.
Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.
BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.
OrbiMed has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
OrbiMed's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Biopharma. The firm invests across 32 different industry categories.
Among tracked funding rounds, TigerConnect received $300.0M in a Private Equity round. OrbiMed's total known invested capital is $31.2B.
OrbiMed's average investment size is $108.2M across its portfolio of 288 companies.
Recent OrbiMed portfolio additions include Harvest Integrated Research Organization, Puma Biotechnology, TigerConnect, Gennao Bio, Emergence Therapeutics. These companies were founded in 2020 or later.